United States · FDA National Drug Code directory
Buprenorphine and Naloxone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2981_3acfd469-5c34-4b0f-982f-77430ab099d6
- Product NDC
- 71335-2981
- Form
- TABLET
- Composition / generic term
- Buprenorphine and Naloxone
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200413
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 42 TABLET in 1 BOTTLE, PLASTIC (71335-2981-0) · 71335-2981-0
- 30 TABLET in 1 BOTTLE, PLASTIC (71335-2981-1) · 71335-2981-1
- 60 TABLET in 1 BOTTLE, PLASTIC (71335-2981-2) · 71335-2981-2
- 90 TABLET in 1 BOTTLE, PLASTIC (71335-2981-3) · 71335-2981-3
- 120 TABLET in 1 BOTTLE, PLASTIC (71335-2981-4) · 71335-2981-4
- 14 TABLET in 1 BOTTLE, PLASTIC (71335-2981-5) · 71335-2981-5
- 28 TABLET in 1 BOTTLE, PLASTIC (71335-2981-6) · 71335-2981-6
- 6 TABLET in 1 BOTTLE, PLASTIC (71335-2981-7) · 71335-2981-7
- 10 TABLET in 1 BOTTLE, PLASTIC (71335-2981-8) · 71335-2981-8
- 21 TABLET in 1 BOTTLE, PLASTIC (71335-2981-9) · 71335-2981-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →